Nocturnal Enuresis More Common in Children With Sleep Apnea
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 3, 2024 -- Nocturnal enuresis is more common in children with obstructive sleep apnea (OSA), according to a study published online Sept. 23 in Children.
María Andreu-Codina, from Universitat Internacional de Catalunya in Barcelona, Spain, and colleagues assessed the prevalence of nocturnal enuresis in children with OSA, the effect of adenotonsillectomy, and the width of the arches. The analysis included 51 children with OSA and nocturnal enuresis, 79 with OSA without nocturnal enuresis, and 168 controls.
The researchers found that nocturnal enuresis was present in 39.2 percent of children with OSA versus 28 percent in the control group. After adenotonsillectomy, nearly half of the children with OSA and nocturnal enuresis significantly improved (49 percent). Compared with the control group, both OSA groups had narrower arch widths. Children with OSA and nocturnal enuresis had the narrowest widths.
"These conclusions underscore the importance of recognizing nocturnal enuresis as a potential clinical marker of OSA in pediatric patients, highlighting the need for early intervention and appropriate management strategies to improve patient outcomes," the authors write. "Future research should aim to include larger samples and consider alternative methods to gather more accurate sleep behavior data."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-04 06:00
Read more
- 20th Century Lead Exposures Took Grim Toll on Americans' Health
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds, such as Wegovy, Zepbound
- American Heart Association, Nov. 16-18
- Need Some 'Alone Time'? It's Vital to Mental Health for Many
- Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions